RecruitingNCT05498584

Targeting LOXL2 and Cardiac Fibrosis for Post-acute Heart Failure Treatment- A Prospective Study


Sponsor

Chang Gung Memorial Hospital

Enrollment

130 participants

Start Date

Aug 25, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

A previous study demonstrated that a multidisciplinary cardiac rehabilitation (CR) program was associated with reduced medium- to long-term all-cause mortality in a retrospective propensity score-matched study. The investigators will further investigate the predictors including LOXl2, cardiac MRI, and endothelial function that will benefit from a successful CR.


Eligibility

Min Age: 20 YearsMax Age: 100 Years

Inclusion Criteria4

  • Patients must give written informed consent before any assessment is performed.
  • Inpatients \>= 20 years of age, male or female.
  • Patients with a diagnosis of heart failure New York Heart Association (NYHA) class II-IV with BNP \>=100 pg/mL or NT-porBNP \>= 400 pg/mL ( \>= 900 pg/mL if concomitant atrial fibrillation)
  • Left ventricular ejection fraction \<= 40% by echocardiography or other methods

Exclusion Criteria8

  • Estimated survival time \< 6 months
  • Long-term bedridden for more than 3 months
  • Cannot tolerate exercise test due to muscular skeletal disorder.
  • Cannot cooperate all functional studies
  • Ventilator dependent
  • Terminal heart status
  • Family rejects to participate in this project
  • Primary severe valvular heart disease

Interventions

BEHAVIORALexercise based cardiac rehabilitation

The types of exercise are treadmill walking/walking-jogging/jogging, ergometer cycling, stair climbing, or elliptical machine training. The training intensity is gradually increased fortnightly to reach the targeted Borg's rate of perceived exertion (RPE) of 12-14. The training duration is 40 minutes, which included 5-10 minutes of warm-up and cool-down exercises. The training frequency is three sessions per week, with 36 sessions concluding a complete course.


Locations(1)

Chang Gung Memorial Hospital Heart Failure Center

Kaohsiung City, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05498584


Related Trials